NBIX
Neurocrine Biosciences, Inc.
171.50
1 x 158.11
1 x 171.90
bid
ask
+
3.73
2.22%
10:16 AM
timesize
| Ytd | 20.92% | |
| 1y | 32.53% |
168.26
day range
172.25
122.14
52 week range
172.25
| Open | 169.10 | Prev Close | 167.77 | Low | 168.26 | High | 172.25 | Mkt Cap | 17.23B |
| Vol | 108.41K | Avg Vol | 1.24M | EPS | 6.49 | P/E | 26.40 | Forward P/E | 13.32 |
| Beta | 0.40 | Short Ratio | 4.97 | Inst. Own | 103.80% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 12-29 | Earning | 07-29 | 50-d Avg | 153.26 | 200-d Avg | 142.25 | 1yr Est | 195.99 |
| Income Statement | |||
| Total Revenue | 814.50M | ||
| Revenues (USD) | 814.50M | ||
| Cost of Revenue | 13.80M | ||
| Gross Profit | 800.70M | ||
| Operating Expenses | 635.90M | ||
| Research and Development Expense | 296.20M | ||
| Selling, General and Administrative Expense | 318.50M | ||
| Operating Income | 164.80M | ||
| Income Tax Expense | 48.90M | ||
| Net Income | 197.90M | ||
| Net Income Common Stock | 197.90M | ||
| Net Income Common Stock (USD) | 197.90M | ||
| Consolidated Income | 197.90M | ||
| Earnings per Basic Share | 1.97 | ||
| Earnings per Basic Share (USD) | 1.97 | ||
| Earnings per Diluted Share | 1.91 | ||
| Earning Before Interest & Taxes (EBIT) | 246.80M | ||
| Earning Before Interest & Taxes (USD) | 246.80M | ||
| Weighted Average Shares | 100.50M | ||
| Weighted Average Shares Diluted | 103.40M | ||
| Balance Sheet | |||
| Cash and Equivalents | 266.50M | ||
| Cash and Equivalents (USD) | 266.50M | ||
| Investments | 2.53B | ||
| Investments Current | 1.05B | ||
| Investments Non-Current | 1.48B | ||
| Trade and Non-Trade Receivables | 768.10M | ||
| Current Assets | 2.44B | ||
| Property, Plant & Equipment Net | 538.00M | ||
| Total Assets | 4.91B | ||
| Total Debt | 406.20M | ||
| Current Liabilities | 831.70M | ||
| Debt Non-Current | 406.20M | ||
| Total Liabilities | 1.50B | ||
| Accumulated Retained Earnings (Deficit) | 589.60M | ||
| Accumulated Other Comprehensive Income | 400.00K | ||
| Shareholders Equity | 3.41B | ||
| Shareholders Equity (USD) | 3.41B | ||
| Assets Non-Current | 2.47B | ||
| Total Debt (USD) | 406.20M | ||
| Inventory | 64.50M | ||
| Liabilities Non-Current | 667.10M | ||
| Trade and Non-Trade Payables | 773.00M | ||
| Tax Assets | 381.40M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 10.00M | ||
| Net Cash Flow from Financing | -86.10M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -446.50M | ||
| Capital Expenditure | -9.10M | ||
| Net Cash Flow - Business Acquisitions and Disposals | 63.20M | ||
| Issuance (Purchase) of Equity Shares | -30.40M | ||
| Net Cash Flow from Investing | -506.20M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -560.30M | ||
| Net Cash Flow from Operations | 145.80M | ||
| Share Based Compensation | 57.20M | ||